Sign in

Global Therapeutic Respiratory Devices Market Analysis and Research Report 2022-2032 | FMI

Ganesh Shinde
Global Therapeutic Respiratory Devices Market Analysis and Research Report 2022-2032 | FMI

The Therapeutic Respiratory Devices Market was valued at US$ 47 billion in 2021 and is expected to reach US$ 68.62 billion by 2032, growing at a CAGR of 3.5% from 2022 to 2032.

The increased prevalence of respiratory disorders, as well as rapid technological advancements, are driving sales of therapeutic respiratory devices. Furthermore, the market is expected to grow as more therapeutic respiratory devices, such as humidifiers, nebulizers, and oxygen concentrators, are adopted. Among the various types of respiratory devices available are long-term respiratory therapy for critical care, emergency respiratory devices for rescue applications, and mobile home respiratory devices. The open-access journal Therapeutic Advances in Respiratory Diseases publishes peer-reviewed original research papers, reviews, and scholarly commentary on cutting-edge research and studies in the treatment of respiratory illnesses.

“Physicians and patients choose respiratory therapy devices for the treatment of respiratory problems owing to the medical intervention in both acute and chronic patient care.”

Key Takeaways

  • Existence of modern healthcare facilities in the United States and Canada, the therapeutic respiratory devices market in North America gained over 36% market share in 2021.
  • The Asia Pacific is predicted to expand the quickest throughout the forecast period, owing to factors such as increased asthma incidence in adults and children, as well as technology improvements.
  • Additionally, the market expansion would be aided by rising healthcare awareness and improved healthcare infrastructure.
  • The clinical trial of Tempol for the treatment of COVID-19 by Adams Respiratory Therapeutics Inc has surpassed enrollment expectations.
  • COPD is estimated to affect 10% of adults aged 75 and older in the United States, according to the Journal of the Italian Society of Gerontology and Geriatrics.
  • According to statistics issued by the Global Initiative for Asthma (GINA), an estimated 100 million people with asthma are expected to be diagnosed by 2025.

Competitive Landscape

Carefusion Corporation, G.E. Healthcare, Chart industries, Philips Healthcare, Compumedics Ltd., Smiths Medical, Covidien PLC, Invacare, Fisher and Paykel, and Mindray are some of the major respiratory device companies.

Acquisitions and mergers, the launch of new products and services, partnerships and joint ventures, MoU agreements, V.C. and funding activities, R&D activities, and geographic expansion, among other noteworthy activities by key players in the therapeutic respiratory devices market, are among the key strategic developments in the competitive landscape.

  • Acapella, a select blue vibratory PAP therapy device, was released by Smiths Medical in April 2021. It is a drug-free supplementary therapy for people with asthma, COPD, cystic fibrosis, and lung illness that aids in the evacuation of secretions.
  • Koninklijke Philips N.V. finalized the acquisition of BioTelemetry, Inc., a firm located in the United States, in February 2021. This aided in the expansion of Philips’ product line, resulting in increased sales of therapeutic respiratory devices.

Key Segments

By Product:

  • Positive Airway Pressure (PAP) Devices
  • Continuous Positive Airway Pressure (CPAP) Devices
  • Auto-titrating Positive Airway Pressure (APAP) Devices
  • Bi-level Positive Airway Pressure (BiPAP) Devices
  • Oxygen Concentrator
  • Fixed Oxygen Concentrators
  • Portable Oxygen Concentrators
  • Ventilators
  • Adult Ventilators
  • Neonatal Ventilators
  • Inhalers
  • Metered Dose Inhaler (MDI)
  • Dry Powder Inhaler (DPI)
  • Soft Mist Inhaler (SMI)
  • Nebulizers
  • Compressor-based Nebulizers
  • Piston-based Hand-held Nebulizers
  • Ultrasonic Nebulizers
  • Humidifiers
  • Heated Humidifiers
  • Passover Humidifiers
  • Integrated Humidifiers
  • Built-in Humidifiers
  • Standalone Humidifiers
  • Others

By Application:

  • COPD
  • Obstructive Sleep Apnea
  • Asthma
  • Respiratory Distress Syndrome
  • Cystic Fibrosis
  • Others

By End-use:

  • Hospital
  • Homecare Settings
  • Emergency Centers

Get More Details@ https://www.futuremarketinsights.com/reports/therapeutic-respiratory-devices-market

Ganesh Shinde
Zupyak is the world’s largest content marketing community, with over 400 000 members and 3 million articles. Explore and get your content discovered.
Read more